In the WT-NASH group, up-regulation of Mrp3 and decreased Mrp2 function, along with reduced Oatp uptake, elevated SFB-G AUC by 165-fold. This evidence concerns the gene SLCO1A2 and metabolic dysfunction-associated steatohepatitis.